Loading
Stephan Targan

Stephan Targan

Executive Director, F. Widjaja Inflammatory Bowel Disease Institute, Cedars-Sinai
Stephan Targan, MD, bases his translational and basic research programs on an integrated science paradigm. His programs focus primarily on immunopathologic mechanisms, novel therapeutics and the translation of basic science findings for use in diagnosis, prognosis and targeted therapeutic selection in inflammatory bowel disease. Human in vitro and animal model are used in genetic and immunobiologic investigations to elucidate the dysregulated immune responses in the gastrointestinal tract that lead to mucosal inflammation.
Sessions

BIO DOUBLE HELIX SPONSOR

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

Loading

BIO HELIX SPONSORS